MLchartDataset catalogue

HIF2alpha inhibitor DFF332

Term · Oncology and biomedicine · MLC-T-ONC-014121

An inhibitor of hypoxia inducible factor (HIF)-2alpha, with potential antineoplastic activity. Upon administration, HIF-2alpha inhibitor DFF332 targets and binds to HIF-2alpha, thereby preventing HIF-2alpha heterodimerization and its subsequent binding to DNA. This results in decreased transcription and expression of HIF-2alpha downstream target genes, many of which regulate tumor cell growth and survival. Blocking HIF-2alpha reduces the proliferation of HIF-2alpha-expressing tumor cells. HIF-2alpha, a heterodimeric transcription factor overexpressed in many cancer cell types, promotes proliferation, progression and metastasis of tumors.

Table 1. Record
IdentifierMLC-T-ONC-014121
FieldOncology and biomedicine
SynonymsHIF-2a inhibitor DFF332
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014121",
  "term": "HIF2alpha inhibitor DFF332",
  "field": "Oncology and biomedicine",
  "definition": "An inhibitor of hypoxia inducible factor (HIF)-2alpha, with potential antineoplastic activity. Upon administration, HIF-2alpha inhibitor DFF332 targets and binds to HIF-2alpha, thereby preventing HIF-2alpha heterodimerization and its subsequent binding to DNA. This results in decreased transcription and expression of HIF-2alpha downstream target genes, many of which regulate tumor cell growth and survival. Blocking HIF-2alpha reduces the proliferation of HIF-2alpha-expressing tumor cells. HIF-2alpha, a heterodimeric transcription factor overexpressed in many cancer cell types, promotes proliferation, progression and metastasis of tumors.",
  "synonyms": [
    "HIF-2a inhibitor DFF332"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/hif2alpha-inhibitor-dff332/"
}

Record 8,489 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.